<- Go Home
Illumina, Inc.
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally.
Market Cap
$19.5B
Volume
2.1M
Cash and Equivalents
$920.0M
EBITDA
$635.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$2.9B
Profit Margin
66.34%
52 Week High
$174.52
52 Week Low
$89.00
Dividend
N/A
Price / Book Value
13.54
Price / Earnings
-6.37
Price / Tangible Book Value
246.11
Enterprise Value
$21.4B
Enterprise Value / EBITDA
28.04
Operating Income
$205.0M
Return on Equity
-76.19%
Return on Assets
1.44
Cash and Short Term Investments
$994.0M
Debt
$2.9B
Equity
$1.4B
Revenue
$4.4B
Unlevered FCF
$907.1M
Sector
Life Sciences Tools and Services
Category
N/A